Aditxt (ADTX) EBT Margin (2022 - 2026)
Aditxt (ADTX) recorded quarterly EBT Margin of 133145.82% in Q1 2026, up 89.18% quarter-over-quarter from 1230882.59% in Q4 2025, and up 45157569.0% on a YoY basis from N/an in Q1 2025.
Aditxt (ADTX) EBT Margin (2022 - 2026) Analysis & Trends
Aditxt's EBT Margin history runs 5 years deep, the most recent figure standing at 133145.82% for Q1 2026.
- In Q1 2026, EBT Margin rose 45157569.0% year-over-year to 133145.82%; the TTM figure through Mar 2026 stood at 369864.52% (down 32268012.0% YoY), while the FY2025 annual figure was 1339187.57%, down 131305028.0% from the prior year.
- EBT Margin was 133145.82% for Q1 2026 at Aditxt, up from 1230882.59% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 2338.9% in Q3 2022 to a low of 3236319.39% in Q3 2025.
- Historically, EBT Margin has averaged 369007.22% across 5 years, with a median of 17218.99% in 2024.
- The sharpest annual moves came in 2025 and 2026: EBT Margin tumbled 313447648 bps in 2025, then soared 45157569 bps in 2026.
- A 5-year view of EBT Margin shows it stood at 4409.13% in 2022, then tumbled by 206 bps to 13503.35% in 2023, then slumped by 1194 bps to 174714.08% in 2024, then tumbled by 605 bps to 1230882.59% in 2025, then surged by 89 bps to 133145.82% in 2026.
- The last three EBT Margin figures came in at 133145.82% (Q1 2026), 1230882.59% (Q4 2025), and 3236319.39% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -133,145.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133,145.82% |
| Dec 31, 2025 | -1,230,882.59% |
| Sep 30, 2025 | -3,236,319.39% |
| Jun 30, 2025 | -736,619.32% |
| Mar 31, 2025 | -584,721.51% |
| Dec 31, 2024 | -174,714.08% |
| Sep 30, 2024 | -101,842.91% |
| Jun 30, 2024 | -17,218.99% |
| Mar 31, 2024 | -18,660.51% |
| Dec 31, 2023 | -13,503.35% |
| Sep 30, 2023 | -7,828.91% |
| Jun 30, 2023 | -2,571.30% |
| Mar 31, 2023 | -2,740.06% |
| Dec 31, 2022 | -4,409.13% |
| Sep 30, 2022 | -2,338.90% |
| Jun 30, 2022 | -2,724.54% |
| Mar 31, 2022 | -2,881.48% |